Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Intangibles (2016 - 2020)

United Therapeutics' Intangibles history spans 10 years, with the latest figure at $128.9 million for Q1 2020.

  • On a quarterly basis, Intangibles rose 7956.25% to $128.9 million in Q1 2020 year-over-year; TTM through Mar 2020 was $128.9 million, a 7956.25% increase, with the full-year FY2019 number at $1.4 million, down 79.1% from a year prior.
  • Intangibles hit $128.9 million in Q1 2020 for United Therapeutics, up from $1.4 million in the prior quarter.
  • Over the last five years, Intangibles for UTHR hit a ceiling of $128.9 million in Q2 2019 and a floor of $400000.0 in Q3 2016.
  • Historically, Intangibles has averaged $22.0 million across 5 years, with a median of $1.7 million in 2016.
  • Biggest five-year swings in Intangibles: crashed 97.42% in 2016 and later skyrocketed 7956.25% in 2020.
  • Tracing UTHR's Intangibles over 5 years: stood at $1.7 million in 2016, then soared by 1688.24% to $30.4 million in 2017, then tumbled by 77.96% to $6.7 million in 2018, then tumbled by 79.1% to $1.4 million in 2019, then surged by 9107.14% to $128.9 million in 2020.
  • Business Quant data shows Intangibles for UTHR at $128.9 million in Q1 2020, $1.4 million in Q4 2019, and $1.5 million in Q3 2019.